Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2022  |  Volume : 35  |  Issue : 3  |  Page : 984-990

Do apheresis platelet concentrates with additive solution offer advantages in vitro or in therapeutic utility?


1 Department of Clinical Pathology, Faculty of Medicine, National Liver Institute, Menoufia University, Menoufia, Egypt
2 Department of Clinical Pathology, National Liver Institute, Menoufia University, Menoufia, Egypt

Correspondence Address:
Amira Z Badawy
Department of Clinical Pathology, Faculty of Medicine, Menoufia University, Menoufia 32511
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/mmj.mmj_279_21

Rights and Permissions

Objective To investigate the in vitro quality of room temperature stored apheresis platelet concentrates (PCs) with and without adding a platelet additive solution (PAS) and to evaluate its therapeutic utility in oncology patients. Background Several studies have highlighted using PAS as a way to improve the storage conditions of PCs. PAS is a synthetic media used in the place of plasma for platelet (PLT) storage. It is used to support metabolism, provide buffering capacity, and to protect PLTs from the storage lesion. So, it can be used to extend shelf life of PCs. To date, its application in Egyptian blood banks has not been increased. Patients and methods Twenty apheresis PCs were collected and stored at room temperature and divided into two groups; A1 group suspended in 100% plasma and tested on days 0 and 5 and A2 group suspended in 65% SSP + PAS and tested on days 0, 5, 7, and 10 of storage for PLT count, mean platelet volume, pH, partial pressure of oxygen, partial pressure of carbon dioxide, bicarbonate level, swirling, bacterial examination, glucose, lactate, lactate dehydrogenase, annexin expression, and PLT aggregation. SSP + PCs were transfused to oncology patients against plasma PCs and the corrected count increment (CCI) was calculated. Results SSP + PCs were comparable to plasma PCs up to day 7 of storage regarding all studied parameters when compared with day 5 of group A1; 7 days SSP + PCs showed a CCI comparable to plasma PCs. Conclusion We reported a maintained PLT function and metabolism up to 7 days of storage of apheresis PCs in 65% SSP + with a CCI comparable to plasma PCs.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed654    
    Printed38    
    Emailed0    
    PDF Downloaded75    
    Comments [Add]    

Recommend this journal